Engflag

Cocaine

Quick links to important sections

Cocaine

Cocaine_PL

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Cocaine

Understanding Cocaine

Cocaine is a potent stimulant substance derived from the leaves of the Erythroxylum coca plant, which is native to South America. It is classified as a central nervous system stimulant and is known for its ability to increase levels of neurotransmitters in the brain, particularly dopamine.

Physical Characteristics and Forms

Cocaine typically appears in two main chemical forms:

  • Cocaine Hydrochloride: This is a white, crystalline powder. It is water-soluble and is most commonly processed for intranasal use (snorting) or intravenous injection.
  • Cocaine Base (Crack): This form has been processed with ammonia or sodium bicarbonate (baking soda) and water to create a solid substance. It is typically found in the form of small "rocks" or chips and is intended for inhalation through heating.

Mechanisms of Action

Cocaine interacts directly with the brain's reward system. Under normal physiological conditions, dopamine is released by neurons in response to rewarding stimuli and is then recycled back into the cell that released it. Cocaine acts by blocking the dopamine transporter, which prevents the reabsorption of the neurotransmitter.

This process results in an accumulation of dopamine in the synaptic cleft, leading to intensified signaling between neurons. This chemical buildup is responsible for the characteristic feelings of increased energy, alertness, and euphoria associated with the substance.

Historical Context

For centuries, indigenous populations in the Andes Mountains have chewed coca leaves for their mild stimulant effects and to combat the rigors of high-altitude living. In the mid-19th century, the active alkaloid was first isolated from the leaves. In the late 19th and early 20th centuries, it was utilized in various tonics and early medical applications before its potential for dependence and its impact on the central nervous system were fully understood.

Regulatory References

  1. Cocaine Hydrochloride Product Label (NIH/DailyMed)

What side effects are possible with Cocaine?

Possible Side Effects and Safety Information

The officially documented safety profile for Cocaine is primarily defined by the risks associated with its effects on the Cardiovascular System and Central Nervous System (CNS).

Frequency-Classified Adverse Reactions

Adverse reactions are classified based on their observed frequency in clinical studies. Common adverse reactions (occurring in over 1% of individuals) reported include:

System/Organ Class Common Adverse Reactions
Nervous System Headache
Vascular/Cardiac Hypertension (high blood pressure), Tachycardia (increased heart rate)
Respiratory Epistaxis (nosebleed)

Serious Adverse Reactions and Safety Concerns

The drug carries significant safety warnings due to its potential to cause severe adverse events. These serious events include:

  • Seizures and lowering of the convulsive threshold.
  • Cardiovascular Events, such as myocardial ischemia, myocardial infarction (heart attack), and ventricular arrhythmias, particularly when used with other vasoconstrictors.

Safety-Related Restrictions and Contraindications

Use is formally restricted in certain populations or conditions, which establishes the boundaries of the drug's safe application:

  • Cardiovascular History: Avoid use in patients with a recent or active history of uncontrolled hypertension, unstable angina, myocardial infarction, coronary artery disease, or congestive heart failure.
  • Concurrent Use: Avoid use of additional vasoconstrictor agents (e.g., epinephrine) due to the increased risk of severe cardiovascular events.
  • Lactation: Breastfeeding is not recommended; a lactating woman should pump and discard breast milk for 48 hours following treatment.
  • Geriatric Patients: Older patients may be more susceptible to cardiovascular adverse reactions and require extra caution.

Regulatory documentation requires specific monitoring for vital sign changes, heart rhythm, and the potential development of seizures following administration.

Overdose and Emergency Response

Overdose and When to Seek Help

Official government regulatory documentation outlines specific manifestations and mandatory actions required in cases of systemic toxicity or overdose involving cocaine hydrochloride solution.

Overdose, which can result from excessive dosage or rapid systemic absorption, primarily affects the Central Nervous System (CNS) and the Cardiovascular (CV) system. Documented signs of toxicity begin with CNS excitation, which can include restlessness, confusion, anxiety, and tremors. These symptoms may progress rapidly to severe outcomes, including clonic-tonic convulsions and dangerous hyperthermia.

Simultaneously, the CV system is subject to severe effects such as intensive hypertension, tachycardia, and life-threatening cardiac arrhythmias. The most serious documented consequences include respiratory arrest from CNS depression and ultimate circulatory failure.

Regulators emphasize that immediate medical attention must be sought for the first signs of systemic toxicity or overdose. Because no specific antidote is known, management is strictly symptomatic and supportive. Treatment procedures described in labeling include the use of benzodiazepines (such as diazepam) to control seizures and specific measures to manage intensive hypertension and reduce elevated body temperature. Resuscitative equipment must be immediately available during the product's use.

Therapeutic Uses of Cocaine

What Cocaine Treats: Main Uses and Benefits

Cocaine, when used in a strictly controlled medical setting, is applied as a topical anesthetic and vasoconstrictor for certain procedures in the head and neck. It is used in areas where short-term symptom management is appropriate.

The medication is utilized for the induction of local anesthesia of the mucous membranes when performing diagnostic procedures and surgeries on or through the nasal cavities in adults.

Easing Localized Pain for Minor Procedures

This medication provides localized numbing (anesthesia) to a confined area, such as the inner lining of the nose or throat, which helps address symptoms related to physical discomfort. It contributes to improved patient comfort and offers symptomatic relief that provides supportive relief when symptoms interfere with routine activities.

Controlling Minor Bleeding and Tissue Swelling

In addition to numbing, this drug helps manage physical symptoms related to irritative states, which is applied in clinical settings marked by heightened patient distress from minor bleeding or swollen tissues. This action helps control and manage minor bleeding and contributes to easing the overall symptom load.

Quick Fact: Relief for Procedural Discomfort The primary patient benefit is the relief of localized pain and the supportive role in managing minor bleeding during acute medical procedures.

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Cocaine Hydrochloride Topical Solution — Official Regulatory Information

Eligibility Scope

Populations for whom use is allowed (as stated in label): Adult patients (18 years of age and older) undergoing diagnostic procedures or surgery on or through the mucous membranes of the nasal cavities.

Populations for whom use is not recommended (if applicable): Pregnant women and nursing mothers.

Populations for whom use is contraindicated: Patients with a known hypersensitivity to cocaine or other ester-based local anesthetics; patients with a history of myocardial infarction, arrhythmia, or uncontrolled hypertension.

Age-related eligibility rules: Approved only for adults (18+); safety and effectiveness are not established in pediatric patients; use requires caution in geriatric patients (65+).

Condition-specific eligibility rules: Contraindicated in uncontrolled hypertension, myocardial infarction, or arrhythmia. Use requires caution in patients with hepatic or renal impairment.

Pregnancy and lactation eligibility status (if explicitly documented): Not recommended during pregnancy (use only if potential benefit justifies risk); not recommended while breastfeeding.

Eligibility-related restrictions: Use is limited to topical application on mucous membranes only.

Eligibility Classifications (High-Level)

Eligibility severity classification (as defined in official documents): Contraindicated, Use Not Established, Not Recommended, Caution.

Regulatory basis (EMA / FDA / etc.): FDA Prescribing Information.

Eligibility-context constraints (as defined in official documents): Restricted to specific diagnostic and surgical procedures on the nasal cavities.

Resulting Eligibility Structure

Official eligibility statements:

  • The medicine is contraindicated in patients with hypersensitivity or specific cardiovascular disease.
  • Safety and effectiveness are not established in pediatric patients.
  • Use is not recommended during pregnancy or lactation.
  • Caution is required for use in geriatric patients and those with hepatic or renal impairment.

Connection to the overall eligibility profile (2–4 sentences): Regulatory documents strictly define who can and cannot use the medicine by primarily permitting its use only in the adult population and prohibiting use based on specific, high-risk cardiovascular comorbidities. Eligibility is further structured by limiting use in patients with organ impairment and excluding populations where safety, such as for pediatric groups, has not been established by regulators.

What should I know about interactions with other medicines?

The official regulatory profile for Cocaine hydrochloride topical solution defines interactions across categories involving both pharmacodynamic and pharmacokinetic mechanisms. The most critical interaction involves pharmacodynamic reinforcement with other vasoconstrictor agents, such as Epinephrine or Phenylephrine. Co-administration is associated with documented adverse cardiovascular events, including myocardial infarction and ventricular arrhythmias. The use of additional vasoconstrictors is consequently restricted, particularly during nasal and sinus surgery.

Regarding metabolic clearance modification, co-administration with Disulfiram is documented to increase plasma cocaine exposure, including peak concentration (C max) and AUC, due to enzyme inhibition, and its use should be avoided. Other inhibitors of plasma cholinesterase may also result in reduced clearance and increased systemic exposure.

A unique interaction occurs with Alcohol (Ethanol), where co-administration leads to the formation of the metabolite cocaethylene. This substance has been found to be more cardiotoxic than cocaine and possesses a longer plasma elimination half-life. Finally, a population-specific note highlights that individuals with officially documented reduced plasma cholinesterase activity may experience reduced clearance of the drug, which increases the risk for these exposure-related interactions.

Mechanism of Action

The mechanism of cocaine is distinguished by two simultaneous and fundamentally different molecular actions that synergistically produce its physiological effects: local nerve impulse blockade and intrinsic vascular tone modulation. The drug primarily acts upon the peripheral nervous system and the local sympathetic pathway.

Inhibition of Peripheral Nerve Conduction

Cocaine's mechanism involves direct interference with the body's nociceptive signaling pathway. The molecule acts as a blocker of voltage-gated sodium channels ( Na v) on sensory nerve membranes. By obstructing these channels, the drug prevents the necessary influx of sodium ions, which is the electrical event required for a nerve impulse to initiate and propagate. This mechanistic domain suppresses the ability of the nerve fibers to transmit sensation. The outcome of this action is the physiological change of localized nerve impulse cessation.

Vascular Tone Modulation Via Adrenergic System Potentiation

The medicine exerts its second core mechanism by modulating the local sympathetic pathway. Cocaine inhibits the Norepinephrine Transporter (NET), a protein responsible for clearing the neurotransmitter Norepinephrine (NE) from the synaptic space. This blockade causes NE to accumulate outside the nerve terminal, leading to the prolonged stimulation of alpha-adrenergic receptors on nearby blood vessel walls. This activation induces a contraction of the vascular smooth muscle, producing the distinct physiological change of localized vasoconstriction (vessel narrowing) at the application site.

Dosage and Administration Information

Cocaine hydrochloride is prepared as a topical solution used exclusively for administration to accessible mucous membranes during defined medical procedures. This medication is not administered orally, intravenously, or intramuscularly; its use is strictly limited to localized application.

Administration is governed by strict dosing parameters. The total amount administered during any single procedure is typically limited by a maximum dose, which should not exceed 160 mg or 3 mg/kg, whichever is less. Maximum dosing recommendations may vary; depending on local clinical guidelines, the limit for topical use may be set at 1.5 mg/kg.

The solution is intended for single administration only, tied to the acute duration of a diagnostic or surgical procedure, precluding any long-term or scheduled use. Administration involves saturating specialized cottonoid or rayon pledgets with the solution. These pledgets are then placed onto the targeted mucosa by a clinician and are generally left in place for a maximum contact time of up to 20 minutes.

Due to the nature of the application, use is confined to controlled clinical settings and must be supervised by personnel skilled in the appropriate procedural techniques. Age-specific rules apply: reduced doses are typically advised for elderly or debilitated patients, and the solution is contraindicated or not recommended in children.

Recent Clinical Evidence

Research evidence / Overview of studies for Cocaine

Evidence for Local Anesthesia in Sinonasal Procedures

Research has focused on its approved use as a local anesthetic, which involves the study of numbing (anesthetic) effects to the mucous membranes lining the nasal passages. This research is relevant in trials assessing short-term or episodic symptom patterns of physical discomfort during procedures.

Researchers have conducted clinical trials, including short-term, randomized, controlled studies, to explore the short-term symptom changes following the topical application of the solution. These studies were carried out in adult populations undergoing various diagnostic or surgical procedures in the nasal cavity. The main outcomes research examined included measurements of subjective pain intensity using rating scales completed by the patient, as well as an assessment of objective anesthetic outcomes, which recorded whether additional numbing agents were necessary during the procedure.

Research on Vasoconstriction and Procedural Support

Research has also explored its intrinsic characteristic as a vasoconstrictor, which involves the study of local blood vessel narrowing. This action is relevant in research contexts involving temporary localized bleeding.

Research has explored this action primarily through pharmacological studies and clinical observations recognized by regulatory bodies. While the controlled anesthetic trials focused mainly on measuring pain relief, the vasoconstrictive property was observed in some studies that describe procedural support, with this effect monitored alongside localized blood flow during the procedure.

However, the vasoconstrictive action is generally not studied as a standalone primary outcome in pivotal efficacy trials. This means comparative evidence against other dedicated vasoconstrictors is lacking, and there is limited specific data on the distinct, measured degree of blood flow management compared to other agents or placebo in modern trials.

Evidence in Special Populations

Research has been conducted primarily in the general adult population, with limited information available for certain groups where physical status may vary.

  • Older Adults: The medicine was evaluated in older adults, and research explored outcomes related to systemic absorption and other measured effects in this group when compared to younger adults.
  • Children: The safety and efficacy of this topical medicine have not been established in the pediatric population. Dedicated clinical studies are still needed to understand the effects of the medicine in children, as regulatory data for this group remain insufficient.

What is Still Uncertain About the Research for Cocaine

  • Long-Term Effects: Follow-up durations were limited, and long-term effects on patient-reported outcomes or systemic health are not well characterized.
  • Subgroup Findings: Data for certain groups, particularly children and individuals with specific serious co-existing conditions, remain insufficient. Results from the core trials apply only to the adult populations studied under controlled conditions.
  • Variability: Research does not determine whether an individual will respond similarly, as study results reflect the specific conditions under which they were conducted.

Key Studies & References

  1. COCAINE HYDROCHLORIDE solution - DailyMed (NIH) Current Labeling Summary
  2. Cocaine (Topical Anesthesia and Vasoconstriction Use) - StatPearls [Internet]

Frequently Asked Questions (FAQ)

Common questions about Cocaine (FAQ)

Q: Does Cocaine interact negatively with common over-the-counter pain relievers or cold medicines?

A: Official product information advises caution when using the drug with other central nervous system (CNS) stimulants or alpha-modifying drugs, which can be components of some over-the-counter cold medicines. Co-administration may potentially increase the risk of CNS effects, such as nervousness or irritability.

Q: Is it normal to experience extreme paranoia or hallucinations during or after using Cocaine?

A: Adverse reactions affecting the Central Nervous System (CNS) are possible. Official labeling indicates that these reactions may be excitatory and can include symptoms such as restlessness, excitement, and confusion.

Q: Can Cocaine use cause long-term cognitive or memory problems?

A: Long-term effects on cognitive function or memory are not well characterized because dedicated long-term animal studies to evaluate such risks have not been conducted. Official documents strictly report on the lack of established long-term data.

Q: What are some of the physical signs that might indicate someone is currently under the influence of Cocaine?

A: Commonly reported physical adverse reactions following administration include elevations in blood pressure (Hypertension) and heart rate (Tachycardia). Patients may also experience a headache.

Q: How long can Cocaine typically be detected in a standard urine or blood drug test?

A: According to official product information, the drug may be detectable in plasma for up to one week following administration. Cocaine and its breakdown products (metabolites) may be found in urine toxicology screens for periods longer than one week.

Q: Can a person develop tolerance to Cocaine, requiring more of the drug to feel the same effect?

A: The drug is officially designated as a Schedule II Controlled Substance due to its high potential for abuse and dependence.

Q: What is the role of Cocaine in the treatment of certain eye, ear, nose, and throat procedures?

A: The topical solution is officially indicated for providing local anesthesia (numbing) to the mucous membranes. Its use is limited to diagnostic procedures and surgeries on or through the nasal cavities in adult patients.

Q: What are the potential interactions between Cocaine and common antidepressant medications (SSRIs)?

A: The official label warns of an increased risk for cardiovascular adverse reactions when the drug is used with alpha-modifying drugs and certain antidepressant medications, such as tricyclic antidepressants.

Q: Is it true that Cocaine can initially increase sex drive but ultimately lead to sexual dysfunction?

A: Official drug information addresses fertility, noting that the medicine may cause changes in a woman's menstrual cycle and a potential reduction in ovulation.

Q: Are the health risks of using Cocaine the same for young people as they are for adults?

A: No, the official regulatory safety and effectiveness of the topical solution have not been established in pediatric patients (children). Use is only approved for adults.

Q: Can Cocaine cause gastrointestinal problems or damage to the stomach/bowels?

A: Systemic reactions due to high plasma levels of the drug may potentially include symptoms like emesis (vomiting) and abdominal pain.

Q: What is the difference between a stimulant and a depressant drug, and how does Cocaine fit in?

A: Cocaine hydrochloride is officially classified by regulators as both a CNS stimulant and an ester local anesthetic. This classification highlights its unique dual effect on the body.

Q: Are there any genetic factors that might make a person more susceptible to Cocaine addiction?

A: The drug is contraindicated (should not be used) in patients with a history of Hereditary pseudocholinesterase deficiency. This is a genetic condition that impacts how the body metabolizes the drug.

Q: What are the long-term effects of Cocaine use on the kidneys and liver?

A: Use is avoided in patients with known hepatic impairment (liver disease). Caution is also required for patients with renal impairment (kidney disease) because these conditions can affect how the body clears the drug.

Q: Can a person experience psychological dependence on Cocaine without severe physical withdrawal symptoms?

A: The drug is a CNS stimulant noted for its high potential for abuse and dependence, which includes psychological dependence.

Q: What are the general research findings on the long-term emotional side effects, like depression, linked to Cocaine?

A: Official research is based on studies with limited follow-up duration. As a result, the long-term effects on patient-reported outcomes or systemic health, including emotional side effects, are not well characterized.

Q: Does using Cocaine once carry a risk of addiction or serious health complications?

A: The drug carries a risk of serious adverse events, including cardiovascular issues such as Myocardial Infarction (heart attack) and Ventricular Arrhythmias, as well as Seizures.

Q: Can Cocaine lead to problems with impulse control and poor judgment?

A: Central Nervous System (CNS) reactions to the drug can be excitatory and are characterized by symptoms like restlessness, confusion, and excitement.

Q: What is Cocaine used for in modern medicine today, if at all?

A: It is indicated for the induction of local anesthesia (numbing) to the mucous membranes when performing diagnostic procedures and surgeries on or through the nasal cavities in adults.

Q: How does Cocaine act as a local anesthetic in a surgical setting?

A: It is classified as an ester local anesthetic and is indicated for use during diagnostic procedures and surgeries on the nasal mucous membranes to provide targeted pain relief and numbing.

Q: What is the chemical substance cocaethylene and why is it dangerous?

A: The substance Cocaethylene is a cardiotoxic metabolite that forms when the drug is present alongside alcohol. This metabolite is associated with an increased risk of sudden death compared to the drug alone.

Q: Why is Cocaine generally not recommended for people with a history of anxiety or other mental health disorders?

A: Official information notes that the drug may lower the convulsive threshold. CNS reactions are often characterized by nervousness and excitement, which may be concerning for individuals with pre-existing anxiety.

Q: Are there any medications or compounds that are known to reverse or counteract a Cocaine overdose in an emergency?

A: The drug label includes a safety warning that resuscitative equipment and drugs should be immediately available when any local anesthetic is used, in case of a serious adverse event.

How should Cocaine be stored and disposed of?

Storage and Disposal of Cocaine Hydrochloride

As a Schedule II Controlled Substance, cocaine hydrochloride solution must be stored and handled according to strict regulatory mandates to maintain its stability and ensure security.

Storage Requirements

The solution must be stored at Controlled Room Temperature (typically 20 C to 25 C) and users must Avoid freezing the product. To preserve product quality, the solution must be Protected from light and kept in its original container with the lid tightly closed. Due to the risk of accidental ingestion, the medicine must be stored locked up and kept out of reach of children.

Disposal Instructions

Any unused solution and drug-soaked materials must be discarded in accordance with institutional procedures for CII products. It is prohibited to flush the solution down drains or allow it to enter waterways.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Cocaine found in:

A-Z Index: